Single Pass, Inc. Announces FDA Clearance of its Kronos Biopsy Closure Device

LAKE FOREST, Calif., April 29, 2024 /PRNewswire/ — Single Pass, Inc. is proud to announce that its Class II Kronos biopsy closure device has received clearance from the U.S. Food and Drug Administration (FDA). The FDA has determined the device is substantially equivalent to predicate…